Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.53% | 74.15 | 0.0% | $2393.32m | |
| NVAX | Novavax, Inc. | 4.67% | 175.32 | 99.2% | $1265.25m | |
| SRNE | Sorrento Therapeutics, Inc. | 6.32% | 14.47 | 1.8% | $570.88m | |
| GILD | Gilead Sciences, Inc. | 0.26% | 68.99 | 1.0% | $550.76m | |
| AMGN | Amgen, Inc. | -0.50% | 240.34 | 1.3% | $482.95m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.74% | 625.82 | 2.5% | $439.89m | |
| BNTX | BioNTech SE | 0.60% | 77.54 | 0.0% | $396.78m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.29% | 274.13 | 1.9% | $376.26m | |
| BIIB | Biogen, Inc. | 9.46% | 303.92 | 1.6% | $342.57m | |
| VXRT | Vaxart, Inc. | 4.34% | 9.49 | 0.0% | $297.70m | |
| ILMN | Illumina, Inc. | -13.93% | 343.70 | 3.5% | $276.15m | |
| EBS | Emergent BioSolutions, Inc. | 1.89% | 129.36 | 6.4% | $179.29m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.59% | 103.29 | 1.9% | $169.16m | |
| SGEN | Seattle Genetics, Inc. | -0.58% | 160.86 | 6.0% | $164.85m | |
| IBIO | iBio, Inc. | -4.43% | 3.88 | 0.2% | $162.08m |
Company Profile
Cannabics Pharmaceuticals, Inc. is an early stage biotechnology company, which engages in the development of personalized anti-cancer and palliative treatments. It focuses on the research and development of cannabinoid-based diagnostics, anti-cancer pharmaceuticals, and palliative therapies. The company was founded by Itamar Borochov, Eyal Ballan, and Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.